HOSPIRA INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HOSPIRA INC, and what generic and branded alternatives to HOSPIRA INC drugs are available?
HOSPIRA INC has fifty-one approved drugs.
There are four tentative approvals on HOSPIRA INC drugs.
Summary for HOSPIRA INC
US Patents: | 0 |
Tradenames: | 42 |
Ingredients: | 33 |
NDAs: | 51 |
Drug Master File Entries: | 32 |
Patent Litigation for HOSPIRA INC: | See patent lawsuits for HOSPIRA INC |
Drugs and US Patents for HOSPIRA INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira Inc | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | INJECTABLE;INJECTION | 200403-003 | Dec 1, 2011 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Hospira Inc | MORPHINE SULFATE | morphine sulfate | INJECTABLE;INJECTION | 202515-005 | Nov 14, 2011 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Hospira Inc | BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER | bretylium tosylate | INJECTABLE;INJECTION | 019008-002 | Apr 29, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Hospira Inc | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 065230-003 | Aug 2, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Hospira Inc | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065293-001 | Aug 10, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Hospira Inc | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065226-002 | Apr 21, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HOSPIRA INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hospira Inc | NIPENT | pentostatin | INJECTABLE;INJECTION | 020122-001 | Oct 11, 1991 | 3,923,785 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.